Skip to main content

PGDx Raises $103M in Third Mega Deal of 2021

Baltimore City's Personal Genome Diagnostics (PGDx) has raised $103 million in Series C funding to "go out and sell" its groundbreaking cancer diagnostic technology. The company received FDA clearance for its diagnostic test kit in April 2020; the kit is designed to provide a genomic profile of tissue from a cancer patient. This is Greater Baltimore's third "mega-deal" of more than $100 million in 2021, following SparkPost and Delfi Diagnostics. Via Baltimore Business Journal.


Read More

 
Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927